Page last updated: 2024-08-24
fura-2 and l 663536
fura-2 has been researched along with l 663536 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Celardo, A; Cerletti, C; Evangelista, V; Rotondo, S | 1 |
| Anderson, KM; Bonomi, P; Buyn, T; Dudeja, P; Harris, JE; Meng, J; Ou, D; Sawlani, D; Seed, T | 1 |
Other Studies
2 other study(ies) available for fura-2 and l 663536
| Article | Year |
|---|---|
The endoperoxides/TxA2 analogue, U46619, inhibits human polymorphonuclear leukocyte function.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Calcimycin; Cell Adhesion; Fura-2; Humans; Indoles; Leukotriene Antagonists; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases A; Phospholipases A2; Prostaglandin Endoperoxides, Synthetic; Superoxides; Terpenes; Thromboxane A2; Vasoconstrictor Agents | 1995 |
A 5-lipoxygenase inhibitor at micromolar concentration raises intracellular calcium in U937 cells prior to their physiologic cell death.
Topics: Amiloride; Apoptosis; Calcium; Cell Survival; DNA; Fluoresceins; Fura-2; Humans; Hydrogen-Ion Concentration; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipoxygenase Inhibitors; Male; Prostate; Trypsin; Tumor Cells, Cultured | 1997 |